Schedule 13G ownership disclosure

Arcturus Therapeutics Holdings Inc

Common Stock, par value $0.001 per share · CUSIP: 03969T109

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Balyasny Asset Management L.P.

    Shares: 2,183,985 · Class: 8.04%

  • BAM GP LLC

    Shares: 2,183,985 · Class: 8.04%

  • Balyasny Asset Management Holdings LP

    Shares: 2,183,985 · Class: 8.04%

  • Dames GP LLC

    Shares: 2,183,985 · Class: 8.04%

  • Dmitry Balyasny

    Shares: 2,183,985 · Class: 8.04%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-25-281215
Form type
SCHEDULE 13G
Filer
Arcturus Therapeutics Holdings Inc.
CIK
CIK 1768224
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub